• Publications
  • Influence
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
Hypertension is a mechanism-based toxic effect of drugs that inhibit the vascular endothelial growth factor signaling pathway (VSP). Substantial evidence exists for managing hypertension as a chronicExpand
  • 312
  • 18
  • PDF
One-year survival following early revascularization for cardiogenic shock.
CONTEXT Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute myocardial infarction (AMI). OBJECTIVE To assess the effect of early revascularization (ERV) onExpand
  • 599
  • 16
  • PDF
Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.
BACKGROUND Despite the fact that coronary artery disease is the leading cause of death among women, previous studies have suggested that physicians are less likely to pursue an aggressive approach toExpand
  • 760
  • 11
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.
OBJECTIVES We conducted a prospective multicenter registry in a large metropolitan area to define the clinical characteristics, hospital course, treatment, and factors precipitating decompensation inExpand
  • 367
  • 11
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.
OBJECTIVES Women and men enrolled in the Thrombolysis in Myocardial Infarction (TIMI) IIIB trial of unstable angina and non-Q wave myocardial infarction (MI) were evaluated to determine genderExpand
  • 250
  • 10
  • PDF
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
BACKGROUND: Metoprolol can improve haemodynamics in chronic heart failure, but survival benefit has not been proven. We investigated whether metoprolol controlled release/extended release (CR/XL)Expand
  • 3,890
  • 8
Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock
Background—Although echocardiography is used in diagnosis and management of myocardial infarction, it has not been established whether specific features of cardiac structure or function early in theExpand
  • 144
  • 7
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
  • 119
  • 7
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.
OBJECTIVES The purpose of this study was to estimate heart failure (HF) and cardiomyopathy (CM) rates after adjuvant trastuzumab therapy and chemotherapy in a population of older women withExpand
  • 236
  • 5
Health-related quality of life among early-stage, non-small cell, lung cancer survivors.
BACKGROUND Limited data are available about the physical and mental functioning of individuals diagnosed and treated for early-stage lung cancer. To develop post-treatment guidelines and targetedExpand
  • 69
  • 5
...
1
2
3
4
5
...